Navigation Links
Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results
Date:5/17/2010

tain our previous levels of profitability including on account of our ability to manage growth, intense competition, wage increases in China, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, our ability to successfully complete and integrate potential acquisitions, withdrawal of governmental fiscal incentives, political instability and regional conflicts and legal restrictions on raising capital or acquiring companies outside China. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our S-1 dated June 27, 2008, our Quarterly Report on Form 10-Q for the quarter ended September 30, 2009, our 10-K for the year ended December 31, 2008, and other recent filings. These filings are available at http://www.sec.gov . We may, from time to time, make additional written and oral forward-looking statements, including statements contained in our filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statements that may be made from time to time by or on our behalf.

About Non-GAAP Financial Measures

To supplement the Company's consolidated financial statements, which statements are prepared and presented in accordance with GAAP, we use the following non-GAAP financial measures: non-GAAP adjusted net income, and non- GAAP adjusted EPS. The presentation of this financial information is not intended to be considered in isolati
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai
2. Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
3. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
4. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
5. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
6. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
7. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
8. Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.
9. Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
10. Poniard Pharmaceuticals, Inc. to Present Additional Cancer Treatment Data Found Significant by TapeBeat.Com Investors
11. Lotus Pharmaceuticals, Inc. Appoints OTC Division Head
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Adaptive Biotechnologies announced today that Chad Cohen , ... as Chair of the Audit Committee. As ... finance, treasury and accounting functions. Since joining Zillow in ... accounting functions, and led the finance organization through Zillow,s ... named Puget Sound Business Journal,s CFO of the year. ...
(Date:3/3/2015)... YORK , March 3, 2015 Fried, ... Jeffrey I.D. Lewis has joined the Firm ... resident in the New York ... handles trademark matters, as well as other intellectual property ... patent attorney, Mr. Lewis represents both plaintiffs and defendants ...
(Date:3/3/2015)... , March 3, 2015  Thingee Corporation, a software ... delivering a presentation entitled, "Technology Adoption: Making Reps, Lives ... through Innovations and Technology ,  in Deerfield ... to 13, 2015. Audiences looking to learn how technology ... want to be in the audience for the Thingee ...
(Date:3/3/2015)... Liberty Corner, New Jersey (PRWEB) March 03, 2015 ... in NJ, has announced today that it has ... DE. Terms of the transaction were not ... engineering consulting services to the energy sector including ... gas, alternative energy, and fossil and nuclear power ...
Breaking Biology Technology:Adaptive Biotechnologies adds Chad Cohen, Zillow Group CFO, to Board of Directors 2Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 2Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 3Thingee to present at 11th Annual Synergistix Users Conference 2
... new USP 797,regulations, which become effective June 1st, ... minimums has the potential of creating new,hazards for ... Microtest, Inc., Issued by the U.S. Pharmacopoeia, ... sampling and testing as a minimum,requirement, in place ...
... Initiate Phase II Trial for IPLEX(TM) in Retinopathy ... Sept. 23 ,Insmed Inc. (Nasdaq CM: INSM), a ... AB, a biopharmaceutical company,dedicated to the development of ... premature birth, today noted the presentation of,clinical study ...
... Phase 4 Study Initiated Pre-Registration,-, COLLEGEVILLE, Pa., ... (NYSE: WYE ), today announced the initiation ... a major study in,adults of an investigational 13-valent ... the leading cause of bacterial pneumonia,in adults., ...
Cached Biology Technology:New USP 797 Regulations May Create New Hazards for Compounding Pharmacy Directors 2New USP 797 Regulations May Create New Hazards for Compounding Pharmacy Directors 3Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 2Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 3Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 4Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 5Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins 2Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins 3Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins 4Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins 5
(Date:2/23/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... for DISTRIBUTED VOICE DIRECTED PAYMENT METHOD AND ... new groundbreaking payment method. Payment accounts may be selected ... be accessed if both the speech (the word associated ...
(Date:2/12/2015)... Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... patent 62/113114 for DISTRIBUTED METHOD AND SYSTEM ... The patent further establishes NXT-ID,s position in the emerging ... portfolio the ability for multiple devices to collaborate with ...
(Date:2/5/2015)... 2015  Marken is starting its 35 th ... a new marketing campaign to solidify its place as ... campaign focuses on First as a primary ... The first headline in the series, ... its client,s priorities. Marken recognizes the need to protect ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken Launches New Patient-Centric Campaign 2
... College of Georgia nurse researcher is among the first in ... through the American Recovery and Reinvestment Act of 2009. ... and the research of African-Americans in the Augusta community who ... to create or save more than 3.5 million jobs over ...
... Darwin described the sudden origin of flowering plants about 130 ... have yet to solve. But a new University ... online edition of the Proceedings of the National Academy ... with information about what the first flowers looked like and ...
... key to Komodo Dragon,s hunting strategy. A new ... Dragon bite is a combination of highly specialized serrated ... accepted theory that prey die from septicemia caused by ... sophisticated medical imaging techniques, an international team led by ...
Cached Biology News:MCG researcher among first to receive NIH stimulus funding 2University of Florida study provides insight into evolution of first flowers 2University of Florida study provides insight into evolution of first flowers 3A combined tooth-venom arsenal revealed as key to Komodo dragon's hunting strategy 2
... Nutating Mixer is a combination of an ... three dimensional action while providing gentle, thorough ... unit can be used for a variety ... specimens, tissue culture, immunoblots, staining/destaining, chromatography, etc. ...
... GenElute™ Agarose Spin Columns are designed for the ... kb DNA from agarose gels. The DNA band ... the spin column. Embedded within the base of ... filters that hold agarose and impurities back while ...
...
... The Synaptic Vesicles Isolation Kit provides ... an enriched synaptic vesicle fraction. The ... lysis of the synaptosomes, and differential ... gradient. The kit also contains an ...
Biology Products: